MapLight Therapeutics, Inc.

MPLT · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$29-$30-$22-$21
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$2-$5-$4-$1
Other Non-Cash-$0$1$0-$0
Operating Cash Flow-$32-$34-$26-$21
Investing Activities
PP&E Inv.-$0-$0$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$142$0$0$0
Inv. Sales/Matur.$7$18$38$33
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$136$17$38$32
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$199$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$198-$0-$0$0
Financing Cash Flow$198-$0-$0$0
Forex Effect$0$0$38$0
Net Chg. in Cash$31-$17$50$11
Supplemental Information
Beg. Cash$34$50$0$28
End Cash$64$33$50$38
Free Cash Flow-$32-$34-$26-$22
MapLight Therapeutics, Inc. (MPLT) Financial Statements & Key Stats | AlphaPilot